Daxor Corp
Research Daxor Corp (DXR) on Bullrun: market cap USD 58.91M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDXR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 58.91M
- Financial periodFY2011
- RevenueUSD 1.45M
- Revenue growth-8.4%
- Net income-USD 7.19M
- Free cash flow-USD 6.63M
- Gross margin54.9%
Valuation Snapshot
latest market cap is USD 58.91M.
About Daxor Corp
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Frequently asked questions
What is Daxor Corp's market cap?
Daxor Corp's market capitalization is USD 58.91M.
What does Daxor Corp do?
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.